Wild Argentinian Amaryllidaceae, a New Renewable Source of the Acetylcholinesterase Inhibitor Galanthamine and Other Alkaloids [PDF]
Molecules, 2012 The Amaryllidaceae family is well known for its pharmacologically active alkaloids. An important approach to treat Alzheimer’s disease involves the inhibition of the enzyme acetylcholinesterase (AChE).
Gabriela E. Feresin +7 more
doaj +2 more sources
Stereocontrolled Synthesis of (−)-Galanthamine [PDF]
Organic Letters, 2007 AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Satcharoen, V. +4 more
openaire +5 more sources
4a,5,9,10,11,12-Hexahydro-6H-benzo[a]cyclohepta[hi]benzofuran - Synthesis of Unnatural Galanthamine Analogs [PDF]
Molecules, 2002 The synthesis of an unnatural galanthamine analog is ...
Ulrich Jordis, Matthias Treu
doaj +2 more sources
Quantititative Determination of Lycorine and Galanthamine in and by HPLC-DAD [PDF]
Natural Product Communications, 2014 Lycorine and galanthamine have various biological activities. A reliable HPLC method coupled with DAD detection was developed and validated for the determination of galanthamine and lycorine in Galanthus trojanus and G. cilicicus. A simple method for the
Gulen Irem Kaya +4 more
doaj +2 more sources
Integrating Narcissus-derived galanthamine production into traditional upland farming systems
Scientific Reports, 2021 Alzheimer’s disease (AD) is a disorder associated with progressive degeneration of memory and cognitive function. Galantamine is a licenced treatment for AD but supplies of the plant alkaloid that it is produced from, galanthamine, are limited.
M. D. Fraser +4 more
doaj +1 more source
Chemical Survey of Three Species of the Genus Rauhia Traub (Amaryllidaceae)
Plants, 2022 Plant biodiversity is an important source of compounds with medicinal properties. The alkaloid galanthamine, first isolated from Galanthus woronowii (Amaryllidaceae), is approved by the FDA for the palliative treatment of mild to moderate Alzheimer’s ...
Luciana R. Tallini +7 more
doaj +1 more source
Frontiers in Chemistry, 2023 As global ageing deepens and galanthamine is the preferred clinical drug for the treatment of mild to moderate Alzheimer’s disease, it will be valuable to examine the behaviour and mechanism of galanthamine’s thermal decomposition for its quality control,
Chong Qin +3 more
doaj +1 more source
Molecules, 2023 Light-emitting diodes (LEDs) have emerged as efficient light sources for promoting in vitro plant growth and primary and secondary metabolite biosynthesis. This study investigated the effects of blue, red, and white-red LED lights on plant biomass growth,
Emilia Morańska +7 more
doaj +1 more source
Fluorometric determination of galanthamine
BUNSEKI KAGAKU, 1962 Yoji ICHIMURA, Kazumitsu NISHIMOTO
openaire +3 more sources
Cloning and characterization of a norbelladine 4'-O-methyltransferase involved in the biosynthesis of the Alzheimer's drug galanthamine in Narcissus sp. aff. pseudonarcissus. [PDF]
PLoS ONE, 2014 Galanthamine is an Amaryllidaceae alkaloid used to treat the symptoms of Alzheimer's disease. This compound is primarily isolated from daffodil (Narcissus spp.), snowdrop (Galanthus spp.), and summer snowflake (Leucojum aestivum).
Matthew B Kilgore +6 more
doaj +1 more source